REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 87 filers reported holding REGENXBIO INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,538,316 | -10.6% | 883,146 | +8.6% | 0.00% | 0.0% |
| Q2 2023 | $16,262,451 | +13.0% | 813,529 | +6.9% | 0.00% | 0.0% |
| Q1 2023 | $14,386,677 | +86415.6% | 760,797 | +3.8% | 0.00% | 0.0% |
| Q4 2022 | $16,629 | -99.9% | 733,245 | +3.6% | 0.00% | -33.3% |
| Q3 2022 | $18,701,000 | +8.2% | 707,573 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $17,284,000 | -24.0% | 699,768 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $22,756,000 | +4.2% | 685,639 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $21,838,000 | -21.7% | 667,853 | +0.4% | 0.00% | -25.0% |
| Q3 2021 | $27,894,000 | +8.3% | 665,419 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $25,746,000 | +20.2% | 662,708 | +5.5% | 0.00% | +33.3% |
| Q1 2021 | $21,418,000 | -9.7% | 627,937 | +20.0% | 0.00% | -25.0% |
| Q4 2020 | $23,731,000 | +74.8% | 523,188 | +6.0% | 0.00% | +33.3% |
| Q3 2020 | $13,578,000 | -27.8% | 493,396 | -3.4% | 0.00% | -25.0% |
| Q2 2020 | $18,808,000 | +18.5% | 510,678 | +4.2% | 0.00% | 0.0% |
| Q1 2020 | $15,872,000 | -58.0% | 490,210 | -46.9% | 0.00% | 0.0% |
| Q4 2019 | $37,792,000 | +131.7% | 922,444 | +101.4% | 0.00% | 0.0% |
| Q3 2019 | $16,308,000 | -26.6% | 458,093 | +6.0% | 0.00% | -20.0% |
| Q2 2019 | $22,206,000 | -4.9% | 432,291 | +6.1% | 0.01% | -16.7% |
| Q1 2019 | $23,346,000 | -26.5% | 407,374 | -46.2% | 0.01% | +20.0% |
| Q4 2018 | $31,778,000 | +24.3% | 757,576 | +123.7% | 0.01% | -28.6% |
| Q3 2018 | $25,566,000 | +19.9% | 338,629 | +14.0% | 0.01% | 0.0% |
| Q2 2018 | $21,321,000 | +174.3% | 297,167 | +14.1% | 0.01% | +133.3% |
| Q1 2018 | $7,773,000 | -5.9% | 260,412 | +4.9% | 0.00% | 0.0% |
| Q4 2017 | $8,256,000 | +1.9% | 248,328 | +1.0% | 0.00% | 0.0% |
| Q3 2017 | $8,099,000 | +78.4% | 245,822 | +6.9% | 0.00% | +50.0% |
| Q2 2017 | $4,540,000 | +37.3% | 229,907 | +34.2% | 0.00% | +100.0% |
| Q1 2017 | $3,306,000 | +7.8% | 171,346 | +3.6% | 0.00% | 0.0% |
| Q4 2016 | $3,068,000 | +36.3% | 165,397 | +2.9% | 0.00% | 0.0% |
| Q3 2016 | $2,251,000 | +299.1% | 160,729 | +127.8% | 0.00% | – |
| Q2 2016 | $564,000 | -8.6% | 70,571 | +23.5% | 0.00% | – |
| Q1 2016 | $617,000 | -23.9% | 57,142 | +16.9% | 0.00% | – |
| Q4 2015 | $811,000 | – | 48,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |